Kishida H, Tada Y, Tetsuoh Y, Yamazaki Y, Saito T, Fukuma N, Hata N, Yasutake M, Hayakawa H
Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
Am Heart J. 1991 Dec;122(6):1554-61. doi: 10.1016/0002-8703(91)90271-i.
To study the effects of stepwise early treatment in variant angina pectoris, frequencies of cardiac events and complications were examined after three different types of treatment. The subjects of the study consisted of 159 consecutive patients with variant angina pectoris, who were in need of hospitalization. The three treatment modalities were the introduction of calcium antagonists, nicorandil and nitroglycerin infusion, and percutaneous transluminal coronary angioplasty (PTCA), respectively. The cardiac event rate for this series of patients was 16% (25 of 159). The cumulative cardiac event rate was 22% at 1 year and 23% at 3 years in the first treatment period; 11% at the same intervals in the second treatment period; and 6% at the same intervals in the third treatment period. Our results suggest that it is important in the treatment of variant angina pectoris not only to prevent anginal attacks by the use of fast-acting coronary vasodilators, but also to initiate early revascularization.
为研究逐步早期治疗对变异型心绞痛的影响,在三种不同类型的治疗后,对心脏事件和并发症的发生率进行了检查。该研究的对象包括159例连续的需要住院治疗的变异型心绞痛患者。三种治疗方式分别为使用钙拮抗剂、尼可地尔和硝酸甘油静脉滴注,以及经皮腔内冠状动脉成形术(PTCA)。该系列患者的心脏事件发生率为16%(159例中的25例)。在第一个治疗阶段,1年时的累积心脏事件发生率为22%,3年时为23%;在第二个治疗阶段,相同时间间隔的发生率为11%;在第三个治疗阶段,相同时间间隔的发生率为6%。我们的结果表明,在变异型心绞痛的治疗中,不仅使用速效冠状动脉扩张剂预防心绞痛发作很重要,而且早期进行血运重建也很重要。